HEPATOCELLULAR CARCINOMA, CHILDHOOD

Clinical trials for HEPATOCELLULAR CARCINOMA, CHILDHOOD explained in plain language.

Never miss a new study

Get alerted when new HEPATOCELLULAR CARCINOMA, CHILDHOOD trials appear

Sign up with your email to follow new studies for HEPATOCELLULAR CARCINOMA, CHILDHOOD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with tough liver cancer: immune therapy trial opens

Disease control Recruiting now

This study is testing whether an immunotherapy drug called pembrolizumab (KEYTRUDA®) can help control liver cancer that has come back or hasn't responded to other treatments in children and young adults. The trial will enroll up to 18 participants under age 30 to see if the drug …

Matched conditions: HEPATOCELLULAR CARCINOMA, CHILDHOOD

Phase: PHASE2 • Sponsor: Allison O'Neill, MD • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

HEPATOCELLULAR CARCINOMA, CHILDHOOD

Get alerted when new HEPATOCELLULAR CARCINOMA, CHILDHOOD trials appear

New hope for kids with tough liver cancer: immune therapy trial opens